Newsroom

Children’s National Health System is a member of a public-private research collective that was awarded up to $14.8 million from the National Institutes of Health (NIH) to launch a data resource center for cancer researchers around the world in order to accelerate the discovery of novel treatments for childhood tumors.  

Children’s National Health System Urologist Michael Hsieh, M.D., was awarded a National Institutes of Health (NIH) grant to optimize a set of parasite proteins that could alleviate pain in multiple types of bladder inflammation.

Tessie October, MD, MPH, a critical care physician and researcher at Children’s National Health System and Assistant Professor of Pediatrics at The George Washington University, received a perfectly scored K23 grant from the National Institutes of Health (NIH) to study “Enhancing Parent-Provider Communication During Critical Illness.”

Mendel Tuchman, MD, Chief Research Officer, Children’s Research Institute at Children’s National Health System, leads a team that was awarded a $650,000 grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

A $1.92 million grant from the National Institutes of Health (NIH) was awarded to a research team that focuses on new approaches for treatment of relapsed pediatric acute myelogenous leukemia (AML).

Children’s National Medical Center has received a five-year grant from the National Institute of General Medical Sciences, part of the National Institutes of Health.

Children’s National received a five-year grant from the National Institutes of Health to identify reliable early signs of prenatal brain injury caused by congenital heart disease.

Mark L. Batshaw, MD, has been appointed to the new position of Physician-in-Chief at Children’s National Medical Center. The goal of this position is to optimize synergies at Children's National across patient care, research, and education.

Children’s National Medical Center is one of 25 institutions selected by the National Institute of Neurological Disorders and Stroke (NINDS) at the National Institutes of Health (NIH) for a new clinical trial consortium: Network of Excellence in Neuroscience Clinical Trials (NEXT) focused on neurological disorders in adults and children.